In other words, to reveal the association between LVI/lymphangiogenesis and LNM/prognosis, thorough pathological evaluation of LVI/lymphangiogenesis using D2-40 antibody should be performed in liver cancer as well as other gastroenterological cancer. This evidence concerns the gene PDPN and liver cancer.